Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week randomized trial of PBT2 in early Alzheimer's disease
2006-002527-17Phase 2Completed
- Sponsor
- Alterity Therapeutics
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PBT2 in Alzheimer's disease (AD) (3 arms), sponsored by Alterity Therapeutics. Primary endpoint: Safety and tolerability of PBT2. Started Jul 2006; status: completed.
02
Drugs
PBT2
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2006-002527-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002527-17.